Healthcare provider profile · identity verified

Jon S. Strutzenberg, DO

Family Practice · WINNEBAGO, IL · NPI 1174633366

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	790	207
Levothyroxine Sodium	Levothyroxine Sodium	610	116
Amlodipine Besylate	Amlodipine Besylate	505	130
Lisinopril	Lisinopril	499	128
Losartan Potassium	Losartan Potassium	389	105
Rosuvastatin Calcium	Rosuvastatin Calcium	333	86
Omeprazole	Omeprazole	277	75
Metformin Hcl	Metformin Hcl	229	66
Hydrochlorothiazide	Hydrochlorothiazide	219	65
Tamsulosin Hcl	Tamsulosin Hcl	213	60
Escitalopram Oxalate	Escitalopram Oxalate	204	53
Ezetimibe	Ezetimibe	190	49
Januvia	Sitagliptin Phosphate	186	44
Gabapentin	Gabapentin	183	46
Metoprolol Tartrate	Metoprolol Tartrate	183	48
Alprazolam	Alprazolam	178	41
Metoprolol Succinate	Metoprolol Succinate	172	46
Glipizide	Glipizide	170	44
Simvastatin	Simvastatin	168	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	30
Pantoprazole Sodium	Pantoprazole Sodium	158	44
Montelukast Sodium	Montelukast Sodium	143	41
Albuterol Sulfate Hfa	Albuterol Sulfate	140	64
Trazodone Hcl	Trazodone Hcl	117	24
Metformin Hcl Er	Metformin Hcl	115	32
Alendronate Sodium	Alendronate Sodium	113	45
Allopurinol	Allopurinol	105	29
Furosemide	Furosemide	103	29
Farxiga	Dapagliflozin Propanediol	95	22
Tramadol Hcl	Tramadol Hcl	91	35
Atenolol	Atenolol	88	24
Eliquis	Apixaban	86	20
Potassium Chloride	Potassium Chloride	84	16
Fenofibrate	Fenofibrate,micronized	83	22
Famotidine	Famotidine	81	19
Celecoxib	Celecoxib	80	22
Sertraline Hcl	Sertraline Hcl	79	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	78	21
Lovastatin	Lovastatin	75	20
Fluticasone Propionate	Fluticasone Propionate	74	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	74	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	34
Myrbetriq	Mirabegron	69	23
Ozempic	Semaglutide	69	16
Xarelto	Rivaroxaban	69	13
Citalopram Hbr	Citalopram Hydrobromide	67	15
Synthroid	Levothyroxine Sodium	67	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	17
Bupropion Xl	Bupropion Hcl	63	18
Oxybutynin Chloride Er	Oxybutynin Chloride	62	20
Prednisone	Prednisone	62	53
Warfarin Sodium	Warfarin Sodium	56	suppressed
Meloxicam	Meloxicam	55	23
Donepezil Hcl	Donepezil Hcl	54	16
Clonazepam	Clonazepam	49	11
Clopidogrel	Clopidogrel Bisulfate	49	14
Propranolol Hcl	Propranolol Hcl	48	13
Bupropion Hcl Sr	Bupropion Hcl	47	12
Lorazepam	Lorazepam	46	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	45	13
Fenofibrate	Fenofibrate	45	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	11
Ramipril	Ramipril	45	11
Pravastatin Sodium	Pravastatin Sodium	43	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	suppressed
Risperidone	Risperidone	40	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	39	suppressed
Terbinafine Hcl	Terbinafine Hcl	39	15
Meclizine Hcl	Meclizine Hcl	37	15
Glipizide Er	Glipizide	36	11
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Valsartan	Valsartan	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Carisoprodol	Carisoprodol	34	suppressed
Ibuprofen	Ibuprofen	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Tradjenta	Linagliptin	33	suppressed
Verapamil Er	Verapamil Hcl	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	25
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	25
Finasteride	Finasteride	30	suppressed
Irbesartan	Irbesartan	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Amoxicillin	Amoxicillin	27	18
Metolazone	Metolazone	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Fentanyl	Fentanyl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Nabumetone	Nabumetone	24	suppressed
Dutasteride	Dutasteride	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Mirabegron Er	Mirabegron	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Azithromycin	Azithromycin	18	16
Gemfibrozil	Gemfibrozil	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Admelog Solostar	Insulin Lispro	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	15	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	15	suppressed
Verapamil Hcl	Verapamil Hcl	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Naproxen	Naproxen	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Temazepam	Temazepam	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error